19th Annual Scientific Meeting Posters

Click to view abstract. Posters are listed in alpha order by first author.

Investigation of patient perception of clinical trials (Abstract)

Apter

Using ecological momentary assessment to identify adherent clinical trials participants robust prediction of full-study adherence from early adherence (Abstract)

Bower

The Placebo-Control Reminder Script and supplementary instrument properties evaluation of face and content validity (Abstract)

Cohen

Can an unobtrusive AI-based system guide DBS programming to the ventral striatum for OCD (Abstract)

Cohn

Varying the time of day of PANSS administration impacts visit to visit variability in acute schizophrenia clinical trials (Abstract)

Daniel

Estimating the risk benefit ratio of cannabinoids among persons with opioid use disorder attentional bias for pain and opioids as a novel treatment target (Abstract)

De Aquino

The development of an automated EEG-based machine learning pipeline for the detection of Alzheimer’s disease (Abstract)

Fonseca-Sabune

Using ecological momentary assessment to index real-world treatment gains from remotely delivered cognitive and functional skills training (Abstract)

Harvey

Latency distributions in speech during structured psychiatric interviews automated speech analysis as a cognitive biomarker (Abstract)

Hopkins

Comparability of computer versus tablet administration of a functional capacity measure implications for cloud based assessments (Abstract)

Horan

The effect of the Suicide Ideation and Behavior Assessment Tool (SIBAT) on suicidality in two Phase 3 studies (Abstract)

Kajs

Analytical validity of a walk detection and gait algorithm in different wear configurations (Abstract)

Kelly

On the variability of circadian rhythm related actigraphy endpoints between two validated devices (Abstract)

Kemethofer

Using AI driven platform to detect negative symptoms of schizophrenia through facial and acoustic analysis (Abstract)

Khan

Assessments of ADAS Cog administration quality are comparable across expert and non expert reviewers (Abstract)

Kindellan

Regional differences on a measure of functional capacity in healthy controls implications for schizophrenia separation (Abstract)

Klein

An exploratory analysis of intrinsic changes in the PANSS in acute schizophrenia clinical trials (Abstract)

Kott

Baseline inflation in dementia clinical trials an exploratory analysis (Abstract)

Kott

A multimodal approach to the study of suicide risk evidence from an implicit association task (Abstract)

Lamontagne

Metabolic and inflammatory changes underlying accelerated epigenetic aging in bipolar disorder (Abstract)

Lima

Longitudinal ecological momentary assessments of behavioral indicators of avolition in schizophrenia correlate with clinical ratings (Abstract)

Owen

Objective habit metrics associated with medication adherence in a CNS clinical trial population (Abstract)

Pironet

Randomized controlled trial targeting knowledge barriers facilitators and readiness to participate in dementia research the POWER project (Abstract)

Sajatovic

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders (Abstract)

Sankhe

Clinical validation of a novel speech assessment app in amyotrophic lateral sclerosis ALS (Abstract)

Simmatis

Validation of inter-rater agreement thresholds in depression trials implications for rater quality monitoring (Abstract)

Sirbu

Age related cognitive changes in the Cambridge Neuropsychological Test Automated Battery normative sample (Abstract)

Thorp

Blood based biomarkers associated with changes in apathy symptoms pilot analyses of the ADMET2 randomized clinical trial (Abstract)

Tumati

The role of lactate and pyruvate in patients with treatment resistant depression (Abstract)

Wartchow